PHK
ALXN

Point72 Hong Kong’s Alexion Pharmaceuticals ALXN Stock Holding History

Point72 Hong Kong’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-480
Closed -$88K – 2618
2021
Q2 		$88K Sell
480
-5,319
-92% -$913K ﹤0.01% 1346
2021
Q1 		$887K Sell
5,799
-1,118
-16% -$173K 0.03% 685
2020
Q4 		$1.08M Buy
+6,917
New +$889K 0.05% 451
2019
Q4 		– Sell
-1,171
Closed -$115K – 1554
2019
Q3 		$115K Buy
1,171
+1,030
+730% +$116K 0.03% 426
2019
Q2 		$18K Buy
+141
New +$18.2K ﹤0.01% 800
2018
Q3 		– Sell
-437
Closed -$54K – 1299
2018
Q2 		$54K Sell
437
-540
-55% -$63.1K 0.02% 416
2018
Q1 		$109K Buy
977
+947
+3,157% +$113K 0.06% 303
2017
Q4 		$4K Buy
+30
New +$3.65K ﹤0.01% 634
2017
Q2 		– Sell
-263
Closed -$32K – 1105
2017
Q1 		$32K Buy
+263
New +$33.9K 0.04% 325
2016
Q3 		– Sell
-96
Closed -$11K – 912
2016
Q2 		$11K Buy
+96
New +$13.6K 0.01% 419
2015
Q4 		– Sell
-128
Closed -$20K – 530
2015
Q3 		$20K Buy
+128
New +$23.3K 0.03% 102
2015
Q2 		– Sell
-3,828
Closed -$663K – 287
2015
Q1 		$663K Buy
+3,828
New +$693K 0.59% 16

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Point72 Hong Kong's ALXN Position: Q3 2021 in Review

Point72 Hong Kong sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 480 shares — an estimated $88K sold.

Point72 Hong Kong first reported a position in ALXN in Q1 2015 and held it in 12 quarters. The position peaked at $1.08M in Q4 2020. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Point72 Hong Kong reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Point72 Hong Kong sold 480 Alexion Pharmaceuticals shares in Q3 2021, an estimated $88K.
  • Point72 Hong Kong first reported a position in Alexion Pharmaceuticals in Q1 2015 and held it in 12 quarters.
  • Point72 Hong Kong's Alexion Pharmaceuticals position peaked at $1.08M in Q4 2020.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Point72 Hong Kong's 13F filing for Q3 2021, filed 15 Nov 2021.